Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cantor Fitzgerald Reiterates Overweight on IDEAYA Biosciencesto Overweight

Author: Benzinga Newsdesk | September 09, 2025 09:15am
Cantor Fitzgerald analyst Li Watsek reiterates IDEAYA Biosciences (NASDAQ:IDYA) from Overweight to Overweight.

Posted In: IDYA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist